Clinical Trials Directory

Trials / Completed

CompletedNCT00015223

Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5

Methyphendidate in the Treatment of Cocaine Dependent Patients With Adult ADHD

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
0 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is the use of Methylphenidate in the treatment of cocaine dependence and Attention Deficit Hyperactivity Disorder (ADHD) comorbidity.

Detailed description

The objective of this study is to determine the safety and efficacy of methylphenidate in a population of patients who are cocaine dependent and suffer from attention deficit hyperactivity disorder.

Conditions

Interventions

TypeNameDescription
DRUGMethylphenidate

Timeline

Start date
1997-06-01
Primary completion
1999-07-01
Completion
1999-08-01
First posted
2001-04-18
Last updated
2017-01-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00015223. Inclusion in this directory is not an endorsement.

Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5 (NCT00015223) · Clinical Trials Directory